Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer
Giannis Mountzios(Henry Dunant Hospital), George Fountzilas(Aristotle University of Thessaloniki), Nikolaos Angouridakis(Aristotle University of Thessaloniki), Ilias Karasmanis(Aristotle University of Thessaloniki), Konstantinos Markou(AHEPA University Hospital), Vassiliki Kotoula(Aristotle University of Thessaloniki), Ioanna Sfakianaki(Aristotle University of Thessaloniki), Konstantinos Vlachtsis(Aristotle University of Thessaloniki), Elena Fountzilas(European University Cyprus), Angelos Nikolaou(Aristotle University of Thessaloniki), Ioannis Konstantinidis(Papageorgiou General Hospital), Ioannis Kostopoulos(Aristotle University of Thessaloniki), Sofia Leva(Papageorgiou General Hospital)
Cited by 45
Related Papers
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
|Journal of Clinical Oncology|2010|488
Clinical trial design in the era of precision medicine
|Genome Medicine|2022|279
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
|Cancer Research|2011|266
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
|Cancer Discovery|2023|181